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To examine the effect of phospholipids on PON1 activities, purified PON1 was exposed to phospholipids prior to the determination of
arylesterase and paraoxonase activities. Phosphatidylcholines with saturated acyl chains (C10–C16) showed a stimulation of both activities, chain
length-dependent, with a greater stimulation of arylesterase activity, suggesting the implication of lipid bilayer in the stimulatory action. Such a
preferable stimulation of arylesterase activity was more remarkable with phosphatidylcholines with polyunsaturated acyl chains or oxidized chains
at sn-2 position, implying that the packing degree of acyl chain may be also important for the preferable stimulation of arylesterase activity.
Separately, 1-palmitoyl-lysoPC also stimulated arylesterase activity preferably, indicating that the micellar formation of lipids around PON1 also
contributes to the stimulatory action. Additionally, phosphatidylglycerols slightly enhanced arylesterase activity, but not paraoxonase activity. In
contrast, phosphatidylserine and phosphatidic acid (≥0.1 mM) inhibited both activities Further, such a preferable stimulation of arylesterase
activity by phosphatidylcholines was also reproduced with VLDL-bound PON1, although to a less extent. These data indicate that
phosphatidylcholines with polyunsaturated acyl chains or oxidized chain, or lysophosphatidylcholine cause a preferable stimulation of arylesterase
activity, thereby contributing to the decrease in the ratio of paraoxonase activity to arylesterase activity.
© 2006 Elsevier B.V. All rights reserved.Keywords: PON1; Arylesterase; Paraoxonase; Preferable stimulation; Phospholipid; Acyl chain; Unsaturation; Oxidized1. Introduction
Paraoxonase1 (PON1), exclusively associated with HDL,
has the ability to hydrolyze organophosphate compounds,
aromatic carboxylic acid esters, and some lactone compounds
[1–4]. In addition to the potential role of PON1 in
detoxification of toxic organophosphates [5–7], another
interest in the enzyme is that PON1 may exert antiatherogenic
action [3,7,8]. The role of PON1 in atherosclerosis develop-
ment was demonstrated in studies using mice lacking PON1Abbreviations: PON1, paraoxonase1; PC, phosphatidylcholine; PE, phos-
phatidylethanolamine; PI, phosphatidylinositiol; PG, phosphatidylglycerol; PS,
phosphatidylserine; PA, phosphatidic acid; PAF, 1-hexadecyl-2-acetyl-phos-
phatidylcholine; LPC, palmitoyl-lysophosphatidylcholine; HDL, high density
lipoprotein; VLDL, very low density lipoprotein; Trp, tryptophan
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doi:10.1016/j.bbamem.2006.03.022[7] or PON1-knock-out mice [9], or overexpressing PON1
[10,11]. Antiatherogenic actions of PON1 include protection of
HDL-associated PON1 against oxidative stress [8,9,11–15];
attenuation of macrophage oxidative stress [11], inhibition of
oxidized LDL-induced MCP-1 production in endothelial cells
[14], and stimulation of HDL-mediated cholesterol efflux from
macrophages [15]. Noteworthy, among HDL subfractions,
HDL3, which carries the high PON1 activity, is efficient in
reverse cholesterol transport [16]. Further, PON1 is a more
potent antioxidant and stimulant of macrophage cholesterol
efflux in HDL-bound state than in lipid-deficient state [17],
suggesting that antiatherogenic function of PON1 may be
expressed in lipid-bound state. In addition, the composition of
HDL may be also important for the function of PON1 as
suggested from the change of PON1 arylesterase activity
during the transition from HDL to pre beta HDL [18].
Noteworthy, there was a remarkable reduction of arylesterase
activity in lipid-deficient PON1, whereas a negligible change
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interaction between PON1 activities and lipids needs further
clarification.
Previous studies showed that in contrast to a negligible
change of arylesterase activity, there was frequently the
reduction of serum paraoxonase activity in some oxidative
stress-associated disease patients [19,20], as well as with
smoking and advancing age [21,22], indicating that the
preferential decrease of paraoxonase activity was associated
with oxidative stress.
One explanation for preferential decrease of paraoxonase
activity may be suggested from the differential effect of some
negatively-charged oleoylated lipids on PON1 activities [23].
Alternatively, it is quite possible that the preferable stimulation
of arylesterase activity by HDL lipids, susceptible to the redox
state in vivo [22], may result in the preferential reduction of
paraoxonase activity of PON1. There have been reports [22,24]
that the level of oxidized phospholipids was enhanced in
lipoproteins of oxidative stress-associated state, where the
preferential reduction of paraoxonase activity have been
frequently observed [19–22]. Previously, it had been found
that PON1 arylesterase activity was stimulated by some
phospholipids including phosphatidylcholine [25,26]. Mean-
while, during a lengthy exposure to oxidized phosphatidylcho-
line, PON1 arylesterase activity was reported to be inactivated
[27].
Thus, the contrasting effect between phosphatidylcholine
and oxidized phosphatidylcholine remains to be clarified.
Therefore, an extensive study, employing phospholipids
differing in the headgroup as well as the size of fatty acyl
chain [28,29], is to be explored to elucidate the mode by
which phospholipids interact with PON1 molecule. Further-
more, it would be worthwhile to find out the type of
phospholipids responsible for the preferential stimulation of
PON1 arylesterase activity, which may contribute to the
reduction in the ratio of paraoxonase activity to arylesterase
activity [19–22].
In this study, we examined the effect of various phospho-
lipids on two activities of PON1, soluble or lipid-bound, and the
properties of phospholipids expressing the preferable stimula-
tion of PON1 arylesterase activity.
2. Materials and methods
2.1. Materials
All materials were purchased from Sigma Chemical Co. (St. Louis. MO,
USA) unless otherwise noted. Various phospholipids including 1-palmitoyl-2-
(5-oxovaleroyl)-sn-glycerophosphorylcholine, 1-palmitoyl-2-glutaroyl-sn-gly-
cerophosphorylcholine, 1-palmitoyl-2-azelaoyl-sn-glycerophosphocholine or
1-alkyl-2-acetoyl-sn-glycero-phosphocholine as well as lysophosphatidylcho-
line were provided by Avanti Polar Lipids, Inc. (Alabaster, AL, USA).
2.2. Purification of PON1 from human plasma
PON1 was purified from human plasma by chromatographic procedures
according to a slight modification of the published procedures [6,26,30], and
kept in 25 mM Tris buffer containing 1 mM Ca2+ at 4 °C. The purified
enzyme possessed a specific activity of approximately 1018 and0.552 μmole/min/mg protein in the hydrolysis of phenyl acetate and
paraoxon, respectively. The purified PON1, used mainly for this study, was
found to belong to phenotype AB group, based on the dual substrate method
[31].
2.3. Assay of paraoxonase1 (PON1)
Arylesterase activity of PON1 was measured by adding enzyme solution to
0.5 ml of 50 mM Tris buffer, pH 7.4 containing 1 mM CaCl2 and 1 mM phenyl
acetate as described before [6,26]. Paraoxonase activity was determined in
50 mM Tris buffer (pH 7.4) containing 1 mM CaCl2 and 1 mM paraoxon as
described before [6]. One unit of arylesterase activity is expressed as 1 μmol of
phenol produced per min, and one unit of paraoxonase activity, as 1 nmol of p-
nitrophenol produced per min.
2.4. Isolation of lipoproteins
Lipoprotein fractions, VLDL (d<1.006 g/ml) and HDL (d=1.063–1.21 g/
ml), were isolated from human serum by density-gradient ultracentrifugation
[32]. Lipoproteins, after dialysis against phosphate-buffered saline (PBS), pH
7.4 containing 1.5 mMKH2PO4, 8.1 mM Na2HPO4, 137 mMNaCl and 2.0 mM
KC1, were stored at 4 °C.
2.5. Preparation of liposomes
Liposome preparation was carried out according to previous publication [33]
with some modification. Briefly, phospholipids, dissolved in chloroform/
methanol, was subjected to vacuum drying, and the lipid film was sonicated
vigorously for 5 min under N2 in 50 mM Tris buffer (pH 7.4) using
dismembrator (Branson sonifier 250) to give a stock solution of phospholipids
(final concentration, 1 mM).
2.6. Effect of lipids on PON1 activities
Purified PON1 (5 arylesterase unit/ml) was preincubated with various
concentrations (1–400 μM) of lipids in 0.1 ml of 50 mM Tris buffer pH, 7.4
containing 1 mM CaCl2 at 25 °C for 30 min, and then 20 μl was taken for assay
of hydrolysis of phenyl acetate [30]. Similarly, PON1 (5 arylesterase unit/ml)
was exposed to various concentrations (1–400 μM) of phospholipids in 0.1 ml
of 50 mM Tris buffer, pH 7.4 containing 1 mM CaCl2 at 25 °C for 30 min and
then 50 μl was taken for assay of hydrolysis of paraoxon. Separately, the effect
of oxidized phosphatidylcholine, lysophosphatidylcholine or PAF on PON1
activities was determined as described above.
2.7. Effect of phospholipids on VLDL-bound PON1
VLDL-bound PON1 (0.2 unit arylesterase/ml) was preincubated with
phospholipids in 0.1 ml of 50 mM Tris buffer, pH 7.4 containing 1 mM CaCl2 at
25 °C, and 30 min later, aliquots (20 μl or 50 μl) were taken for assay of
arylesterase and paraoxonase activities.
2.8. Molecular sieve chromatography of liposomes
The size distribution of liposome was determined according to published
procedures [34,35] with minor modifications. In brief, 1 ml of liposomes (1 mM)
was applied to a Sepharose 4B column (1.5×20 cm), which was eluted with
50 mM Tris (pH 7.4) containing 1 mMCaCl2 and 100 mMNaCl at a flow rate of
0.2 ml/min. Each fraction (0.5 ml) was collected, and monitored for the
absorbance at 208 nm or 300 nm [34,35].
2.9. Effect of phospholipids on PON1 Trp fluorescence
PON1 (5 unit arylesterase/ml, 0.1 μM) was preincubated with various
concentrations (100–400 μM) of DMPC or DPPS in 1 ml of 50 mM Tris (pH
7.4) containing 1 mM CaCl2 at 25 °C. After 30 min preincubation, the
fluorescence emission spectra of PON1 Trp residue in the presence or absence of
phospholipid were monitored [36] using Perkin-Elmer 550-55 Fluorimeter at 25
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widths of 10 nm.
2.10. Determination of Emax, Emed or EC50 values
The potency of each phospholipid in stimulating PON1 activity was
evaluated on the basis of Emax, Emed or EC50 values. Emax represents the
maximal stimulation % (relative to control) over the range of concentrations
used, and Emed indicates the stimulation % achieved in the presence of each
phospholipid of 30 μM. EC50, the concentration of phospholipids required for
50% maximal stimulation, was determined by fitting the concentration–
stimulation % curve of each phospholipid to hyperbolic function using Sigma
Plot 2000 for Windows as follows; Y=A X/B+X, where X represents the
concentration of phospholipids, Y is the stimulation %, and A and B are
hyperbolic coefficients.
2.11. Statistics
All statistical analyses were performed using a SPSS program for window.
Statistical assessments were performed using ANOVA for the initial
demonstration of significance at P<0.05, followed by post hoc Duncan's
multiple-range test [37].
3. Results
3.1. Effect of various phospholipids on PON1 activities
Previously, it was observed that some negatively-charged
lysophospholipids or monounsaturated fatty acids caused the
reduction in ratio of paraoxonase activity to arylesterase activity
by inhibiting PON1 paraoxonase activity preferentially [23].
Separately, the preferable stimulation of PON1 arylesterase
activity may lead to the reduction in ratio of paraoxonase
activity to arylesterase activity. To see the preferable stimulationFig. 1. Effect of phospholipids on arylesterase activity of PON1. A, PON1 (5 arylester
0.1 ml of 50 mM Tris buffer (pH 7.4) containing 1 mM Ca2+ at 25 °C, and then the a
Tris buffer, pH 7.4 containing 1 mM CaCl2 and 1 mM phenyl acetate as described in
of arylesterase activity of PON1 (control), which was preincubated in the absence of
PON1 (5 arylesterase units/ml) was preincubated with various phospholipids (1–400
paraoxonase activity in 50 mM Tris buffer (pH 7.4) containing 1 mM CaCl2 and
paraoxonase activity of PON1 (control), which was preincubated in the absence ofof PON1 arylesterase by phospholipids, purified PON1 was
preincubated with various phospholipids for 30 min, and then
PON1 activities, after 25-fold dilution, was determined using
paraoxon or phenyl acetate as substrate. First, when PON1 was
preincubated with 1-palmitoyl-2-myristoyl-PC (PMPC) at
various concentrations (1–400 μM), both arylesterase activity
and paraoxonase activity were enhanced with arylesterase
activity being more responsive to PMPC (Fig. 1A and B).
Similarly, the exposure of PON1 to sphingomyelin also resulted
in some increase of arylesterase activity but not paraoxonase
activity (data not shown). In contrast, neither dimyristoylpho-
sphatidylethanolamine (DMPE) nor dioleoylphosphatidyletha-
nolamine (DOPE) up to 400 μM had a significant effect on both
activities. Subsequently, when the effect of negatively-charged
phospholipids on PON1 activities was examined, dimyristoyl-
phosphatidylglycerol (DMPG) was found to cause an apparent
increase of arylesterase activity dose-dependently while having
an inhibitory effect on paraoxonase activity. Likewise, soy bean
phosphatidylinositol (PI) enhanced arylesterase activity, but
slightly decreased paraoxonase activity. Meanwhile, dimyris-
toylphosphatidylethanol (DMPEt), negatively-charged, which
showed a significant inhibition (∼20%) of paraoxonase activity
at 0.2 mM, had no effect on arylesterase activity (data not
shown). Thus, soybean PI and DMPG expressed a selective
stimulation of arylesterase activity.
In contrast, dimyristoylphosphatidylserine (DMPS), which
had no significant inhibition of both activities up to 30 μM,
showed a remarkable inhibition of both activities at higher
concentration (0.1–0.4 mM) with a greater inhibition of
arylesterase activity. Likewise, dimyristoylphosphatidic acid
(DMPA) also inhibited both activities remarkably with a greaterase units/ml) was preincubated with each phospholipid (1–400 μM) for 30 min in
liquot (20 μl) was taken for the assay of arylesterase activity in 0.5 ml of 50 mM
Materials and methods. Enzyme activity was expressed as a percentile value (%)
phospholipid. Data are expressed as a mean±S.D. value of triplicate assays. B,
μM) as described above, and then the aliquot (50 μl) was taken for the assay of
1 mM paraoxon. Enzyme activity was expressed as a percentile value (%) of
phospholipids. Data are expressed as a mean±S.D. value of triplicate assays.
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activity vs. 64% inhibition of paraoxonase activity by DMPA
(400 μM).
3.2. Preferable stimulation of PON1 arylesterase activity by
phosphatidylcholines
Compared to paraoxonase activity, arylesterase activity was
more responsive to phosphatidylcholine stimulation. Therefore,
a preferable stimulation of arylesterase activity was further
studied using various types of phosphatidylcholine. As shown
in Fig. 2A and B, both arylesterase activity and paraoxonase
activity of PON1 were enhanced after preincubation with
didecanoylphosphatidylcholine (DDPC) with arylesterase ac-
tivity being more responsive to DDPC; arylesterase activity was
remarkably (Emax, 45%) augmented by DDPC, in contrast to a
modest stimulation (Emax, 33%) of paraoxonase activity (Table
1). A greater stimulation (Emax, 55–63%) of arylesterase
activity was observed after the exposure of PON1 to
dilauroylphosphatidylcholine (DLPC), dimyristoylphosphati-
dylcholine (DMPC) or dipalmitoylphosphatidylcholine
(DPPC). Among PC series with saturated acyl chains (C10–
C16), the values of Emed values (stimulation % achieved with
0.03 mM lipid) seem to depend on the length of acyl chain as
shown in Table 1. Noteworthy, the efficiency of PC series,
expressed as the ratio of Emed value to EC50 value, in stimulating
arylesterase activity was enhanced in accordance with the
increase of fatty acyl chain length; C10<C12<C14<C16.
However, the extension of acyl chain length over C16 failed to
further enhance the stimulatory action, based on the Emax values;
DPPC (56%) vs. DSPC (29%). Furthermore, such a stimulation
of arylesterase activity was more remarkable with dilinoleoyl-Fig. 2. Stimulatory effect of phosphatidylcholine on PON activities. A, PON1 (5 ar
0.1 ml of 50 mM Tris buffer (pH 7.4) containing 1 mMCa2+ at 25 °C, and then the aliq
Enzyme activity was expressed as a percentile value of arylesterase activity of PON1
mean±S.D. value of triplicate assays. B, PON1 (5 arylesterase units/ml) was preincub
aliquot (50 μl) was taken for paraoxonase activity assay as described in Fig. 1B. Enzym
Data are expressed as a mean±S.D. (bar) value of triplicate assays.phosphatidylcholine (DLnPC), which showed Emax of 78% and
Emed of 58%. Similarly, 1-palmitoyl-2-linoleoylphosphatidyl-
choline (PLnPC) and 1-palmitoyl-2-arachidonoylphosphatidyl-
choline (PAPC) also displayed a remarkable stimulation of
arylesterase activity with Emax values of 74–80% and Emed
values of 57–58%. Thus, the stimulatory effect of phosphati-
dylcholines on arylesterase activity differed according to
property of acyl chain. Nonetheless, there was no remarkable
difference of Emax values (30 to 42%) in the stimulation of
paraoxonase activity by phosphatidylcholines. Overall, the
preferable stimulation of arylesterase activity was more
prominent with phosphatidylcholines containing polyunsaturat-
ed fatty acyl chains than those with saturated ones.
3.3. Preferable stimulation of PON1 arylesterase activity by
oxidized phosphatidylcholine, lysophosphatidylcholine or PAF
Subsequently, we examined the stimulatory effect of
oxidized phosphatidylcholines with aldehyde or acid at the sn-
2 position [38]. As shown in Fig. 3A, arylesterase activity was
more remarkably enhanced after the exposure of PON1 to 1-
palmitoyl-2-(5′-oxo-valeroyl)-phosphatidylcholine (POVPC),
compared to its precursor, 1-palmitoyl-2-arachidonyl-phospha-
tidylcholine (PAPC); the Emax and the EC50 value were 102%
and 3.4 μM for POVPC vs. 74% and 3.0 μM for PAPC (Table 1).
Meanwhile (Fig. 3B), the stimulation of paraoxonase activity
was observed to be similar between POVPC (Emax, 31.1% and
EC50, 15.9 μM) and PAPC (Emax, 30.2% and EC50, 28.9 μM).
Thus, POVPC was more effective than PAPC in exerting a
preferable stimulation of arylesterase activity. Additionally, 1-
palmitoyl-2-glutaroyl-phosphatidylcholine (PGPC), another ox-
idation product of PAPC, exhibited Emax value of 97.9% andylesterase units/ml) was preincubated with each PC (1–400 μM) for 30 min in
uot (20 μl) was taken for the assay of arylesterase activity as depicted in Fig. 1A.
(control), which was preincubated in the absence of PC. Data are expressed as a
ated with each phosphatidylcholine (1–400 μM) as described above, and then the
e activity was expressed as a percentile value of paraoxonase activity of control.
Table 1
Emax, Emed and EC50 of each lipid in the stimulation of purified PON1 activities
Phospholipids Emax (%) Emed (%) EC50 (μM)
Substrate Phenyl acetate Paraoxon Phenyl acetate Phenyl acetate Paraoxon
Control 0 0 0
+DDPC 44.6±1.5a 33.0±2.1 12.5±8.2a 71.08±4.6a 128.24±6.2
+DLPC 63.4±3.4b 32.8±4.8 35.5±5.4b 25.36±2.9b –
+DMPC 62.6±5.5b 39.6±0.7 45.8±2.6c 7.60±0.5c 87.56±5.8
+DPPC 56.2±1.9bc 36.9±1.3 47.1±2.5c 5.47±1.4c 34.28±1.2
+DSPC 28.6±0.9d – 18.3±2.6a 12.3±1.2d –
+DOPC 64.9±4.4ce 41.5±1.2 47.9±4.3c 3.27±0.3e 22.96±2.8
+PLnPC 80.1±1.7e 32.8±10.8 57.1±3.0d 3.41±0.9e 22.03±1.3
+PAPC 74.1±5.1e 30.2±1.2 58.3±4.2d 3.01±0.8e 28.92±2.1
+DLnPC 78.1±1.9ce 34.4±4.9 57.9±3.3d 4.52±1.1e 23.56±3.2
+POVPC 102.0±3.5f 31.1±1.6 76.1±7.6f 3.41±0.9e 15.93±2.6
+PGPC 97.9±2.2f 26.5±3.5 68.6±2.2f 4.14±0.8e 14.60±1.5
+AzPC 91.8±10.4f 7.6±4.9 69.4±3.4f 5.29±0.9e –
+PAF 87.8±10.0 29.2±3.1 49.8±4.4 17.54±2.1 19.93±1.7
+LPC 134.1±18.2 29.8±3.6 38.9±3.8 52.40±4.0 59.00±6.4
Emax, Emed and EC50 values were determined as described in Materials and methods.
–, not measured; control, without phospholipids; Emax, maximal stimulation %; Emed, stimulation % in the presence of 30 μM lipid; EC50, concentration required for
50% maximal stimulation. Means with the same letter are not significantly different (P<0.05, n=3).
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Emax value of 27% and EC50 value of 14.6 μM in the hydrolysis
of paraoxon. A similar result was also observed with 1-
palmitoyl-2-azelaoyl-phosphatidylcholine (AzPC), showing
Emax value of 91% and 7.6% in the hydrolysis of phenyl acetate
and paraoxon, respectively, compared to its precursor (PLnPC),
which showed Emax value of 80% in the hydrolysis of phenyl
acetate, and Emax value of 33% in the hydrolysis of paraoxon.
Thus, AzPC was also more efficient than its precursor, PLnPC,
in exerting a preferable activation of arylesterase activity.
Overall, oxidized phosphatidylcholines with shorter acyl chainsFig. 3. Stimulatory effect of oxidized phosphatidylcholine, LPC or PAF on PON1
phosphatidylcholines, PAF or LPC (1–400 μM) for 30 min in 0.1 ml of 50 mM Tris
taken for arylesterase activity assay. Enzyme activity was expressed as a percentile v
value of triplicate assays. B, PON1 (5 arylesterase units/ml) was preincubated with
described above, and then the aliquot (50 μl) was taken for paraoxonase activity. Enzy
Data are expressed as a mean±S.D. (bar) value of triplicate assays.at the sn-2 position seemed to be slightly more effective than
corresponding precursor PCs in expressing a preferential
stimulation of arylesterase activity. However, there was no
significant difference of EC50 values between oxidized PCs and
corresponding precursor PCs. In related study, 1-hexadecyl-2-
acetyl-phosphatidylcholine (PAF) or palmitoyl-lysophosphati-
dylcholine (LPC) was tested for their stimulation of PON1
activities. PAF (Emax, 88%; EC50, 17.5 μM) enhanced
arylesterase activity in a concentration-dependent manner, but
it was less efficacious than oxidized PCs in stimulating
arylesterase activity below 30 μM (Fig. 3A). Paraoxonaseactivities. A, PON1 (5 arylesterase units/ml) was preincubated with oxidized
buffer (pH 7.4) containing 1 mM Ca2+ at 25 °C and then the aliquot (20 μl) was
alue of arylesterase activity of control. Data are expressed as a mean±S.D. (bar)
various oxidized phosphatidylcholines, PAF or C16:0 Lyso PC (1–400 μM) as
me activity was expressed as the percentile value of control paraoxonase activity.
Table 2
Emax, Emed and EC50 of each lipid in the stimulation of VLDL-bound PON1
activities








Control 0 0 0
+DLPC 25.0±3.3 −2.2±4.9 9.9±3.3 29.8±5.8 –
+PLnPC 32.8±3.8 4.3±3.9 21.0±5.3 11.4±3.6 –
+PAPC 34.2±3.8 4.3±4.1 20.2±1.9 17.2±3.1 –
+POVPC 37.7±2.1 6.7±5.2 34.2±1.6 6.6±0.8 –
+PGPC 27.8±4.3 −1.5±7.9 18.5±3.1 9.7±2.6 –
+AzPC 30.2±6.4 7.4±4.5 20.0±3.9 8.8±1.7 –
+LPC 46.6±6.4 8.7±5.8 20.6±2.5 26.7±3.8 –
Emax, Emed and EC50 values were determined as described in Materials and
methods.
–, not measured, control, without phospholipids. Means with the same letter are
not significantly different (P<0.05, n=3).
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although to a less extent than arylesterase activity (Fig. 3B).
Likewise, LPC (Emax, 134%; EC50, 52.4 μM) also stimulated
arylesterase activity remarkably, but it was less stimulatory than
oxidized phosphatidylcholines below 30 μM. Again, paraox-
onase activity was also stimulated by LPC (Emax, 29.8% and
EC50, 59 μM), although to a lower extent than arylesterase
activity.
3.4. Effect of phospholipids on VLDL-bound PON1 activity
Subsequently, we investigated the effect of phospholipids on
VLDL-bound PON1. As seen in Fig. 4 and Table 2,
phosphatidylcholines such as DLPC, PAPC or PLnPC (1–
400 μM) stimulated arylesterase activity (Emax, 25–34% and
EC50, 11.4–29.8 μM), but not paraoxonase activity (Emax, at
≤6.7%), demonstrating a preferable stimulation of VLDL-
associated arylesterase activity. Similarly, POVPC, PGPC or
AzPC (1–400 μM) also expressed a substantial stimulation of
arylesterase activity (Emax, 28–38% and EC50, 6.6–9.7 μM),
but not paraoxonase activity. Although there was no remarkable
difference of Emax values among PCs, the EC50 value of DLPC
was higher than that of the other PCs. Further, the analysis of
Emed values indicates that DLPC is less stimulatory than the
other PCs. Separately, LPC expresses a remarkable stimulation
of VLDL-associated arylesterase activity (Emax, 47%). Thus,
phosphatidylcholines with polyunsaturated acyl chains or
oxidized acyl chains are more efficient than DLPC in expressing
a preferable stimulation of VLDL-bound arylesterase activity,
similar to the finding with purified PON1. Nonetheless, such aFig. 4. Effect of phospholipids on VLDL-bound PON1. PON1 (5 arylesterase
units/ml) was preincubated with various phospholipids (1–400 μM) for 30 min
in 0.1 ml of 50 mM Tris buffer (pH 7.4) containing 1 mM Ca2+ at 25 °C, and
then the aliquot (20 μl) was taken for arylesterase activity assay. Data are
expressed as a mean±S.D. (bar) value of triplicate assays, presented as a
percentage of control activity.stimulatory effect of phosphatidylcholines was not significant
with HDL-bound arylesterase activity, where PON1 might be
tightly associated with phosphatidylcholines in HDL particle
[23].
3.5. Molecular sieve chromatography of phospholipids vesicle
In order to examine which forms of phosphatidylcholines
account for the stimulation of PON1 activity, various phospha-
tidylcholine vesicle preparations were subjected to Sepharose
4B gel chromatography in the elution buffer containing 1 mMFig. 5. Molecular sieve chromatography of phospholipids vesicle. Aliquot (1 ml)
of each phospholipid stock solution (1 mM) was applied to Sepharose 4B
column (1.5×20 cm), which was eluted with 50 mM Tris (pH 7.4) containing
1 mM CaCl2 and 100 mM NaCl at a flow rate of 0.2 ml/min. Each fraction
(0.5 ml) was monitored for absorbance at 300 nm (micelle-free vesicle) or at
208 nm (micelle).
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lipid turbidity, or at 208 nm for PAF.
As shown in Fig. 5, DMPC was found to be eluted in the
front peak corresponding to micelle-free unilamellar vesicles,
in agreement with previous observations [34,35]. Similar
results were also obtained with PLnPC, DLnPC or oxidized
PCs (PGPC or POVPC). In contrast, palmitoyl-lysopho-
sphatidylcholine (LPC) and PAF, when the elution was
monitored at 208 nm [34], appeared much later in
chromatogram, indicating that LPC and PAF behaved as
micellar forms.
3.6. Effect of phospholipids on PON1 Trp fluorescence
Previously [36], the hydrophobic character of Trp residues in
or close to Ca2+-binding sites of PON1 had been demonstrated
to be very important for the enzyme activity. In a related study
to examine the relationship between the effect of phospholipids
on PON1 activities and their effect on PON1 Trp fluorescence
by lipids, it was found DMPC enhanced the Trp fluorescence of
PON1 in a concentration-dependent pattern (0.01–0.4 mM) at a
range of concentrations showing the stimulatory effect on
arylesterase activity (Fig. 6A). Conversely, DMPS caused a
remarkable decrease of PON1 Trp fluorescence (Fig. 6B) at
concentrations (0.1–0.4 mM) showing the inhibitory effect on
arylesterase activity, indicating that there may be a direct link
between the loss of PON1 activities and reduction of PON1 Trp
fluorescence. Similarly, DMPG enhanced PON1 Trp fluores-
cence, but DMPA reduced it (data not shown). Thus, it seems
that stimulatory phospholipids caused the increase in Trp
fluorescence, while the inhibitory phospholipids decrease the
PON1 Trp fluorescence.Fig. 6. Effect of phospholipids on PON1 Trp fluorescence. PON1 (5 unit aryleste
concentrations (10–400 μM) in 1 ml of 50 mM Tris (pH 7.4) containing 1 mM CaCl2
monitored using Perkin-Elmer 550-55 Fluorimeter at 25 °C, with the excitation wavel
2, 10 μMDMPC; 3, 30 μMDMPC; 4, 100 μMDMPC; 5, 200 μMDMPC; 6, 400 μM
200 μM DMPS; 6, 400 μM DMPS.4. Discussion
There have been reports [19–22] on the preferential decrease
of PON1 paraoxonase activity in serum of persons with
oxidative stress-associated pathological signs. Our previous
report [23] demonstrated that monoenoic acids or negatively-
charged lysophospholipids displayed a preferential inhibition of
paraoxonase activity. Here, we demonstrate that the preferable
stimulation of PON1 arylesterase activity by some phosphati-
dylcholines may contribute to the reduction of the ratio of
paraoxonase activity to arylesterase activity.
In present study, the effect of phospholipids on PON1
activities varied greatly according to the type of phospholipids,
with which PON1 was associated. Most of phosphatidylcho-
lines expressed a preferable stimulation of PON1 arylesterase
activity. Among PC series with saturated acyl chains, the
stimulatory action of PC was enhanced in accordance with the
increase of fatty acyl chain length (C10<C12<C14≤16).
Thus, the stimulatory action of PC series seems to be ascribed to
their ability in stabilizing bilayers over micelles [39].
Noteworthy, the greatest stimulation of arylesterase activity
was observed with a chain length of C16, corresponding to a
bilayer of a hydrophobic thickness of ca. 2.4 nm [40],
suggesting that the hydrophobic match between PON1 N-
terminal sequence and phosphatidylcholine bilayer is important
for the maximal stimulation. Alternatively, the greater stimu-
lation by phosphatidylcholine series (C10–C16) with higher Tm
values may imply that the stimulatory action of PC series may
be related to the relative stability of acyl chain in the gel state.
However, the greater stimulation by DOPC (Tm, −21 °C),
compared to DLPC (Tm, −2.5 °C), and no effect of temperature
(15–37 °C) on the stimulatory action of DMPC excludes therase/ml, 0.1 μM) was preincubated with DMPC (A) or DPPS (B) at various
at 25 °C. After 30 min incubation, fluorescence emission spectra of PON1 were
ength of 280 nm and excitation and emission slit widths of 10 nm. (A) 1, control:
DMPC; (B) 1, control: 2, 10 μMDMPS; 3, 30 μMDMPS; 4, 100 μMDMPS; 5,
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[41,42]. Instead, it is suggested that the size of acyl chain region
in PC bilayer may be important for the stimulation of
arylesterase activity. A support for this is from the greater
stimulation by phosphatidylcholines with unsaturated fatty acyl
groups, compared to those with saturated acyl group, suggesting
that the diameter of acyl chain relative to that of polar head
group may be an important factor; the presence of unsaturation
in PC acyl chain is known to disturb the ordered packing of acyl
groups [43,44], and thereby cause a loose packing of
phospholipid bilayer [45], which may facilitate the incorpora-
tion of PON1 N-terminal into phospholipid bilayer. Although
the head group spacing effect was proposed to explain the
activation of PKC activity by polyunsaturated PC series [41],
this is less applicable to the stimulation of arylesterase activity
by DMPC vesicles, which showed a similar degree of
stimulation, irrespective of preparation methods, sonication or
extrusion. Thus, the disorder of acyl chains seems to be more
important for the stimulation of PON1 activity than the head
group spacing. A further support is provided by another finding
that oxidized PC (POVPC, PGPC or AzPC) with shorter and
less non-polar chain at the sn-2 position were no less
stimulatory than PC with unsaturated fatty acyl chains.
Alternatively, the negative curvature effect of oxidized PCs
(POVPC, PGPC or AzPC) could be implicated in their
stimulatory action as had been observed in the activation of
CTP:phosphocholine cytidyltransferase activity by 1-palmitoyl,
2-(11,15-dihydroxy) eicosatrienoyl PC, exerting a more nega-
tive curvature effect than its precursor, PAPC [45]. However,
the negative curvature effect of oxidized PCs (POVPC, PGPC
or AzPC) on PON1 activity may not be remarkable, since the
stimulatory action of oxidized PCs used here is only slightly
greater than that of unsaturated PCs, and the EC50 values, used
as a rough measure of the relative binding affinity, are similar
between oxidized PCs and unsaturated PCs. In addition,
oxidized PCs may be different from palmitoyl-lysoPC, posses-
sing a positive curvature [46], in that they are more stimulatory
than palmitoyl-lysoPC on the basis of Emed and EC50 values.
Moreover, in chromatographic analyses, oxidized PC series
(POVPC or PGPC) behave like bilayer of DMPC or PLnPC, in
contrast to micellar behavior of palmitoyl-lysoPC [47] or PAF
[48]. In this regard, it is supposed that the maximal stimulation
of aryesterase activity is achieved primarily by the anchoring of
PON1 N-terminal to PC bilayer [49]. Additional mode by which
arylesterase activity is stimulated may be the micellar
association of lysophospholipids around N-terminal sequence
or the interface of PON1 [49], which had been proposed to
interact with lipids in HDL particle. In support of the latter, our
unpublished data indicate that DMPC liposome-bound PON1
aryesterase activity was further stimulated by palmitoyl-lysoPC.
Separately, phosphatidylglycerol, despite the negative
charge in phosphodiester linkage, significantly stimulated
arylesterase activity as observed with zwitterionic PC series.
This might be explained by the previous reports [50,51] that
DMPG, in combination with Ca2+, exhibited bilayers of
crystalline-like gel phase with highly ordered acyl chains.
Thus, DMPG and PI may behave like bilayer lipids, associablewith PON1, in the incubation condition containing 1 mM
calcium ion. Nonetheless, DMPG was less stimulatory than PC
series, indicating that the presence of negatively-charged
phosphate group at the bilayer surface of PG may affect the
property of the bilayer interface.
In contrast, DMPE or DOPE, characterized by pyramid type
and negative intrinsic curvature effect [52,53], showed no effect
on arylesterase activity. Additionally, DMPS or DMPA), more
likely to form hexagonal type of micelle in the acidic condition
[54,55], had no remarkable effect on arylesterase activity at low
concentrations (1–30 μM). Meanwhile, at higher concentra-
tions (0.2–0.4 mM), DMPS or DMPA expressed a strong
inhibition of arylesterase and paraoxonase activities in the
presence of Ca2+, which had been reported to form a stable
multilamellar complex with PS at neutral pH [56]. From this, it
is supposed that the inhibition of PON1 activity by DMPS/Ca2+
may be due to the structural constraint of PON1 during Ca2+-
induced adhesion of PS vesicles [56].
Probably in support of this, the inclusion of DMPC in DMPS
vesicle suppressed the inhibitory action of DMPS. Additionally,
apolipoprotein AI, an amphipathic protein [18], restored the
suppressed activity of PON1 in PS vesicle. Meanwhile, no
effect of NaCl (1 M) on the inhibitory action of PS excludes the
implication of electrostatic attraction the inhibition of PON 1 by
DMPS. Such an inhibitory action of DMPS or DMPA at
≥100 μM is in a contrast to the stimulatory action of DMPC or
DMPG at the same concentrations, reflecting a structural
change of PON1 by phospholipids. A support for this may be
from the opposite effects of phospholipids on fluorescence
spectra of PON1 Trp residue [36]. DMPC or DMPG enhanced
PON1 Trp fluorescence with a blue shift, consistent with the
conformational change of Trp residue-containing region in non-
polar lipid [40]. Meanwhile, DMPS or PMPA reduced Trp
fluorescence with no change of emission wavelength, implying
that Trp fluorescence was quenched in polar environment
induced by PS.
Overall, compared to paraoxonase activity, arylesterase
activity is more sensitive to the lipid environment, whatever
type of phospholipids, in agreement with the notion that the
binding site for phenyl acetate may be distinguished from
paraoxon-binding site in PON1 molecule [48]. However, the
inhibitory role of negatively-charged phospholipids is less
likely in in vivo system, since the amount of those lipids is
limited in lipoproteins. Therefore, the ratio of PC series with
unsaturated acyl chain or oxidized chain to those with saturated
chains may be a crucial factor to determine the preferable
stimulation of arylesterase activity. For this purpose, oxidized
PC, expressing a preferable stimulation of arylesterase activity,
may be more efficient than unsaturated PC. Noteworthy, such a
preferable stimulation of PON1 arylesterase activity by PC
series was also observed with VLDL-associated PON1, but not
HDL-associated PON1. This might be explained by the notion
that PON1 in HDL particle, rich in phosphatidylcholine, is
already activated by lipids in HDL, while PON1 is not fully
activated in VLDL particle, rich in triacylglycerol [57].
Additionally, apolipoprotein AI, in combination with phospha-
tidylcholines, is also important for the maximal activation of
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a beneficial effect of apolipoprotein-A1 was not announced
significantly in combination with AzPC (oxidized PC) or
lysoPC (data not shown), suggesting that the stimulation by
oxidized PC with loosely-packed acyl chains or micellar lysoPC
may not require the lipid-dispersing action of apolipoprotein A-
I [59].
Taken together, the present data demonstrate that some
phosphatidylcholine derivatives in HDL particle indirectly
contribute to the reduction in the ratio of paraoxonase activity
to arylesterase activity by exerting a preferable stimulation of
arylesterase activity. In addition to the previous finding [23] that
monounsaturated fatty acids or negatively-charged lysopho-
spholipids directly cause the preferential inhibition of para-
oxonase activity, present data may provide another explanation
for the cause for the relative reduction of paraoxonase activity in
sera of oxidative stress-related disease patients. Therefore, the
level of PC derivatives with unsaturated acyl chain or oxidized
chains, responsible for the preferable stimulation of arylesterase
activity, in HDL particle as well as the amount of preferential
inhibitors (monoenoic acid, lysoPI or lysoPG etc.) of para-
oxonase activity in serum may be responsible for the relative
decrease of PON1 paraoxonase activity in vivo. According to
previous reports [38,60], the oxidation of PC derivatives leads
to the formation of PC containing acid or aldehyde group at sn-2
position, belonging to preferential stimulator of arylesterase
activity. In turn, the hydrolysis of oxidized phosphatidylcholine
by PAF acetylhydrolase or PLA2 can generate lysopho-
sphatidylcholine, another stimulator of arylesterase activity
[61,62]. Finally, the preferable stimulation of arylesterase
activity by oxidized PC and lysoPC would contribute to the
decrease in the ratio of paraoxonase activity to arylesterase
activity, which could be magnified in the presence of
monoenoic acids or negatively-charged lysophospholipids
[23]. Further study on the relationship between the PON1
activity and the composition of phospholipids in HDL particles
of different oxidative status could reveal the physiological
significance of preferential stimulation of PON1 arylesterase
activity.
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